From: Chronic inflammation role in the obesity-diabetes association: a case-cohort study
BMI | Waist | Insulin | ||||
---|---|---|---|---|---|---|
r | P-value | r | P-value | r | P-value | |
Main exposure variables | ||||||
BMI | 0.83 | <0.01 | 0.55 | <0.01 | ||
Waist | 0.83 | <0.01 | 0.53 | <0.01 | ||
Insulin | 0.55 | <0.01 | 0.53 | <0.01 | ||
Inflammation markers and adipokines | ||||||
Adiponectin, in men | −0.23 | <0.01 | −0.25 | <0.01 | −0.30 | <0.01 |
Adiponectin, in women | −0.31 | <0.01 | −0.29 | <0.01 | −0.46 | <0.01 |
C-reactive protein | 0.40 | <0.01 | 0.36 | <0.01 | 0.35 | <0.01 |
IL-6 | 0.29 | <0.01 | 0.32 | <0.01 | 0.19 | <0.01 |
Fibrinogen | 0.24 | <0.01 | 0.22 | <0.01 | 0.20 | <0.01 |
Orosomucoid | 0.32 | <0.01 | 0.33 | <0.01 | 0.31 | <0.01 |
Sialic acid | 0.19 | <0.01 | 0.16 | <0.01 | 0.11 | 0.01 |
White blood count | 0.07 | <0.01 | 0.14 | <0.01 | 0.10 | <0.01 |
Complement component 3 | 0.43 | <0.01 | 0.39 | <0.01 | 0.46 | 0.06 |
Oxidized LDL | 0.06 | 0.12 | 0.10 | 0.01 | 0.07 | 0.06 |
ICAM-1 (ng/mL) | 0.04 | 0.36 | 0.12 | <0.01 | 0.10 | 0.01 |
Leptin, in men | 0.64 | <0.01 | 0.65 | <0.01 | 0.50 | <0.01 |
Leptin, in women | 0.73 | <0.01 | 0.69 | <0.01 | 0.65 | <0.01 |
Other metabolic variables | ||||||
Non-esterified fatty acids | 0.07 | 0.07 | 0.04 | 0.31 | −0.01 | 0.75 |
Systolic blood pressure | 0.24 | <0.01 | 0.24 | <0.01 | 0.33 | <0.01 |
Diastolic blood pressure | 0.21 | <0.01 | 0.20 | <0.01 | 0.27 | <0.01 |
Triglycerides | 0.21 | <0.01 | 0.28 | <0.01 | 0.30 | <0.01 |
HDL-cholesterol, in men | −0.18 | 0.01 | −0.26 | <0.01 | −0.28 | <0.01 |
HDL-cholesterol, in women | −0.28 | <0.01 | −0.32 | <0.01 | −0.36 | <0.01 |
HOMA-IR | 0.55 | <0.01 | 0.53 | <0.01 | 0.99 | <0.01 |
Fasting glucose | 0.26 | <0.01 | 0.30 | <0.01 | 0.44 | <0.01 |